Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Kazia Therapeutics Limited/ADR/ EFFECT

SEC Filing · EFFECT

Kazia Therapeutics Limited/ADR

SEC Filing

Filed Sep 25, 2026Accepted Sep 28, 2026, 12:15 AM EDTCIK 1055886Accession 9999999995-26-003070
View company →Permanent SEC source ↗
Share

Recent company filings

  1. F-6 filingSep 18, 2026
  2. 424B3 filingApr 4, 2025
  3. 424B3 filingOct 16, 2024
  4. 424B3 filingOct 16, 2024
  5. 424B3 filingOct 16, 2024

As-filed source

Primary evidence
As filedOpen full document ↗